While extensive research supports the use of GnRH antagonists to decrease OHSS occurrence, there is a lack of definitive evidence on the efficacy of fixed vs. flexible antagonist protocols specifically in women with PCOS who are hyper responders to ovarian stimulation. This evidence concerns the gene GNRH1 and polycystic ovary syndrome.